Organization
Biostatistics, Indiana University School of Medicine, Indianapolis, IN
8 abstracts
Abstract
The survival benefits and the risk of severe renal injury of immune checkpoint inhibitors in patients with cancer: The real-world evidence from the National Clinical Cohort Collaborative (N3C).Org: Department of Biostatistics and Health Data Science at Indiana University School of Medicine, Indianapolis, IN, Biostatistics, Indiana University School of Medicine, Indianapolis, IN, Palila Software LLC, Reno, NV, Indiana University School of Medicine, Indianapolis, IN, Indiana University, Indianapolis, IN,
Abstract
The role of obesity on outcomes of adoptive cellular therapy in solid tumors.Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Biostatistics, Indiana University School of Medicine, Indianapolis, IN, Department of Investigational Cancer Therapeutics,
Abstract
Predictive factors for cardiac events following concurrent chemotherapy and radiation with durvalumab consolidation for unresectable non-metastatic non-small cell lung cancer.Org: Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Biostatistics, Indiana University School of Medicine, Indianapolis, IN, Feinberg School of Medicine,
Abstract
Exploratory study investigating the efficacy and safety of olanzapine prophylaxis for opioid-induced nausea and vomiting (JORTC-PAL20).Org: National Cancer Center Hospital East, Kashiwa, Japan, Juntendo University Graduate School of Medicine, Biostatistics, Indiana University School of Medicine, Indianapolis, IN, JORTC Data Center, Japanese Organisation for Research and Treatment of Cancer,
Abstract
Integrated efficacy and safety of brigatinib in patients with ALK TKI-naive advanced ALK+ NSCLC in the ALTA-1L and J-ALTA studies.Org: University of Colorado Cancer Center, Sendai Kousei Hospital, Fujita Health University School of Medicine, Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, SongDang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea, Yonsei Cancer Center, Yonsei University Health System,
Abstract
"ROUTINE APGAR-LIKE PATIENT INDEX DATASHEET"(RAPID): A CONTINUOUS INDEX OF PATIENT MEASURES DISCRIMINATES EFFECTIVELY BETWEEN ACTIVE AND PLACEBO TREATMENTS IN 4 ADALIMUMAB CLINICAL TRIALSOrg: Medicine and Frontier Science Center of Disease Molecular Network, Vanderbilt University Medical Center, Nashville, Biostatistics, Indiana University School of Medicine, Indianapolis, IN, Quintiles, Inc.,
Abstract
A META-ANALYSIS OF ANALGESIC EFFICACY OF ROFECOXIB 50 MG FROM 13 CLINICAL STUDIESOrg: Clinical Research Centre, SCIREX Corporation, Austin Health, Clinical Development, Late-Stage Development, Oncology R&D, AstraZeneca, Merck and Co., Inc.,
Abstract
78-WEEK SAFETY DATA FROM THE RANDOMIZED, DOUBLE-BLIND PHASE II/III EXPLORER STUDY OF PATIENTS WITH MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) TREATED WITH RITUXIMAB Org: Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma, Internal Medicine, U. Kansas, Kansas, Rheumatology, U. Chicago, Chicago, Rheumatology, N. Shore LIJ Health System, Lake Success, Rheumatology, Alameda Medical Ctr, Oakland,